15919782	183	Wolf G	From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.	Diabetes	2005	136
12037148	920	Herold KC	Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.	The New England journal of medicine	2002	286
15616015	920	Lindley S	Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.	Diabetes	2005	192
15771578	920	Anderson MS	The NOD mouse: a model of immune dysregulation.	Annual review of immunology	2005	328
20086230	920	Vendrame F	Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.	Diabetes	2010	66
26193635	920	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	34
15919798	925	Herold KC	A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.	Diabetes	2005	175
22213807	925	Coppieters KT	Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.	The Journal of experimental medicine	2012	148
24939063	925	Gomes AC	Gut microbiota, probiotics and diabetes.	Nutrition journal	2014	25
21403038	966	de Boer IH	Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.	Archives of internal medicine	2011	80
25562264	966	Livingstone SJ	Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.	JAMA	2015	42
16505242	1401	Devaraj S	Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.	Diabetes	2006	90
17426276	1440	Voltarelli JC	Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.	JAMA	2007	114
23111057	1440	Fadini GP	Diabetes impairs stem cell and proangiogenic cell mobilization in humans.	Diabetes care	2013	37
25500887	1440	Haller MJ	Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.	The Journal of clinical investigation	2015	32
17329575	1471	Perkins BA	Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.	Journal of the American Society of Nephrology 	2007	107
20332356	1471	Ficociello LH	High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.	Diabetes care	2010	49
20522536	1490	Adler SG	Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.	Clinical journal of the American Society of Nephrology 	2010	49
16167085	1493	Bisikirska B	TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.	The Journal of clinical investigation	2005	94
21205883	1493	Steck AK	Genetics of type 1 diabetes.	Clinical chemistry	2011	49
25634360	1493	Rosenzwajg M	Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.	Journal of autoimmunity	2015	37
20511061	1628	Takiishi T	Vitamin D and diabetes.	Endocrinology and metabolism clinics of North America	2010	50
10752702	1636	-	Variation and trends in incidence of childhood diabetes in Europe. EURODIAB ACE Study Group.	Lancet	2000	98
12788992	1636	Perkins BA	Regression of microalbuminuria in type 1 diabetes.	The New England journal of medicine	2003	160
26009228	1636	Palmer SC	Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.	Lancet	2015	40
7995938	1822	Shultz LD	Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.	Journal of immunology	1995	233
10677521	1822	Yu L	Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2000	129
17088535	1822	Lee RH	Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.	Proceedings of the National Academy of Sciences of the United States of America	2006	190
18178393	1822	Zhang L	Insulin as an autoantigen in NOD/human diabetes.	Current opinion in immunology	2008	73
25157096	1861	Pathiraja V	Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.	Diabetes	2015	25
21355053	1956	Rosolowsky ET	Risk for ESRD in type 1 diabetes remains high despite renoprotection.	Journal of the American Society of Nephrology 	2011	58
8666144	2571	Verge CF	Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.	Diabetes	1996	133
9054945	2571	Pugliese A	The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.	Nature genetics	1997	175
18843118	2571	Ludvigsson J	GAD treatment and insulin secretion in recent-onset type 1 diabetes.	The New England journal of medicine	2008	129
20699420	2571	Keenan HA	Residual insulin production and pancreatic ß-cell turnover after 50 years of diabetes: Joslin Medalist Study.	Diabetes	2010	103
21714999	2571	Wherrett DK	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.	Lancet	2011	91
19120261	2572	TEDDY Study Group.	The Environmental Determinants of Diabetes in the Young (TEDDY) Study.	Annals of the New York Academy of Sciences	2008	71
19741189	2572	Orban T	Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.	Diabetes care	2009	89
22296077	2572	Ludvigsson J	GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.	The New England journal of medicine	2012	72
22441569	2572	Parikka V	Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.	Diabetologia	2012	42
23780460	2572	Ziegler AG	Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.	JAMA	2013	141
12788877	2641	Vilsbøll T	Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.	The Journal of clinical endocrinology and metabolism	2003	95
23183535	2641	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	29
18004301	3105	Nejentsev S	Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.	Nature	2007	151
22102287	3106	Wooldridge L	A single autoimmune T cell receptor recognizes more than a million different peptides.	The Journal of biological chemistry	2012	100
23762245	3115	Jia X	Imputing amino acid polymorphisms in human leukocyte antigens.	PloS one	2013	139
18252895	3117	Erlich H	HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.	Diabetes	2008	186
20798335	3117	Noble JA	HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.	Diabetes	2010	51
8072542	3119	Davies JL	A genome-wide search for human type 1 diabetes susceptibility genes.	Nature	1994	177
14519706	3119	Ziegler AG	Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.	JAMA	2003	102
17244711	3119	Nelson JL	Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism.	Proceedings of the National Academy of Sciences of the United States of America	2007	60
18814906	3119	Näntö-Salonen K	Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.	Lancet	2008	84
24550192	3119	Kallionpää H	Innate immune activity is detected prior to seroconversion in children with HLA-conferred type 1 diabetes susceptibility.	Diabetes	2014	32
14519705	3123	Norris JM	Timing of initial cereal exposure in infancy and risk of islet autoimmunity.	JAMA	2003	109
15889096	3126	Kent SC	Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope.	Nature	2005	113
21564455	3126	Hagopian WA	The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.	Pediatric diabetes	2011	64
25660258	3126	Krischer JP	The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.	Diabetologia	2015	44
17475933	3375	Huang CJ	High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.	Diabetes	2007	135
17501667	3375	Hofbauer LC	Osteoporosis in patients with diabetes mellitus.	Journal of bone and mineral research 	2007	89
21742788	3375	Westermark P	Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.	Physiological reviews	2011	181
17112620	3383	Giulietti A	Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.	Diabetes research and clinical practice	2007	63
9428763	3458	Wilson SB	Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.	Nature	1998	132
11781358	3458	Kukreja A	Multiple immuno-regulatory defects in type-1 diabetes.	The Journal of clinical investigation	2002	160
19074986	3458	Putnam AL	Expansion of human regulatory T-cells from patients with type 1 diabetes.	Diabetes	2009	113
19818653	3458	Feuerer M	How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.	Immunity	2009	91
21368230	3458	McClymont SA	Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.	Journal of immunology	2011	109
23323860	3458	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	62
20173777	3552	Mandrup-Poulsen T	Blockade of interleukin 1 in type 1 diabetes mellitus.	Nature reviews. Endocrinology	2010	63
23562090	3552	Moran A	Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.	Lancet	2013	77
15855327	3553	Brusko TM	Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.	Diabetes	2005	90
22412385	3553	Eizirik DL	The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.	PLoS genetics	2012	94
22461703	3558	Garg G	Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.	Journal of immunology	2012	50
24622415	3558	Hartemann A	Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes and endocrinology	2013	62
25576057	3558	Yu A	Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.	Diabetes	2015	28
19119414	3559	Maier LM	IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.	PLoS genetics	2009	61
19701192	3559	Dendrou CA	Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.	Nature genetics	2009	107
22723342	3559	Marek-Trzonkowska N	Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.	Diabetes care	2012	80
12220549	3569	Ishihara K	IL-6 in autoimmune disease and chronic inflammatory proliferative disease.	Cytokine and growth factor reviews	2002	138
17170049	3569	de Jager W	Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.	Annals of the rheumatic diseases	2007	68
18776137	3569	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	56
21377916	3569	Neurath MF	IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.	Cytokine and growth factor reviews	2011	114
24622416	3569	Gitelman SE	Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.	The lancet. Diabetes and endocrinology	2013	34
26781070	3569	Domingueti CP	Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.	Journal of diabetes and its complications	2016	29
16818678	3575	Liu W	CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.	The Journal of experimental medicine	2006	664
14755342	3586	Arif S	Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.	The Journal of clinical investigation	2004	124
24089515	3586	van Lummel M	Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.	Diabetes	2014	42
24939426	3586	Arif S	Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes.	Diabetes	2014	39
19014637	3605	Zhu X	IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.	Breast cancer research 	2008	72
19748982	3605	Bradshaw EM	Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells.	Journal of immunology	2009	84
20592279	3605	Honkanen J	IL-17 immunity in human type 1 diabetes.	Journal of immunology	2010	71
20810982	3605	Marwaha AK	Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.	Journal of immunology	2010	52
8447318	3630	Spielman RS	Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).	American journal of human genetics	1993	727
9042129	3630	Anderson B	Parental involvement in diabetes management tasks: relationships to blood glucose monitoring adherence and metabolic control in young adolescents with insulin-dependent diabetes mellitus.	The Journal of pediatrics	1997	112
9054944	3630	Vafiadis P	Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.	Nature genetics	1997	148
9450510	3630	Amos AF	The rising global burden of diabetes and its complications: estimates and projections to the year 2010.	Diabetic medicine 	1997	221
9509261	3630	Goodyear LJ	Exercise, glucose transport, and insulin sensitivity.	Annual review of medicine	1998	158
9710447	3630	Barber AJ	Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.	The Journal of clinical investigation	1998	289
10911004	3630	Shapiro AM	Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.	The New England journal of medicine	2000	773
11289033	3630	Ryan EA	Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.	Diabetes	2001	97
11587045	3630	Morrish NJ	Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.	Diabetologia	2001	191
12037147	3630	Diabetes Prevention Trial--Type 1 Diabetes Study Group.	Effects of insulin in relatives of patients with type 1 diabetes mellitus.	The New England journal of medicine	2002	157
12081851	3630	Willett W	Glycemic index, glycemic load, and risk of type 2 diabetes.	The American journal of clinical nutrition	2002	84
12136392	3630	Cryer PE	Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes.	Diabetologia	2002	178
12364302	3630	DAFNE Study Group.	Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial.	BMJ	2002	140
12610045	3630	Steffes MW	Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.	Diabetes care	2003	152
14693724	3630	Palmer JP	C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.	Diabetes	2004	123
15161770	3630	Heise T	Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.	Diabetes	2004	81
15910627	3630	Donnelly LA	Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.	Diabetic medicine 	2005	90
15983207	3630	Ryan EA	Five-year follow-up after clinical islet transplantation.	Diabetes	2005	364
18162506	3630	Edghill EL	Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood.	Diabetes	2008	85
18192540	3630	Molven A	Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes.	Diabetes	2008	52
18319314	3630	Grossmann M	Low testosterone levels are common and associated with insulin resistance in men with diabetes.	The Journal of clinical endocrinology and metabolism	2008	65
18673007	3630	King GL	The role of inflammatory cytokines in diabetes and its complications.	Journal of periodontology	2008	98
18802479	3630	Skowera A	CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.	The Journal of clinical investigation	2008	129
19565214	3630	Hemkens LG	Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study.	Diabetologia	2009	150
19603149	3630	Colhoun HM	Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group.	Diabetologia	2009	100
19915016	3630	Nadeau KJ	Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.	The Journal of clinical endocrinology and metabolism	2010	84
20091571	3630	Misso ML	Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.	The Cochrane database of systematic reviews	2010	57
20103556	3630	Peyrot M	Correlates of insulin injection omission.	Diabetes care	2010	93
20724178	3630	Liu M	Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth.	Trends in endocrinology and metabolism	2010	48
20798346	3630	Unger RH	Paracrinology of islets and the paracrinopathy of diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2010	71
20978091	3630	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	57
21270174	3630	Birkeland KI	Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine.	Diabetes care	2011	43
21367930	3630	Steil GM	The effect of insulin feedback on closed loop glucose control.	The Journal of clinical endocrinology and metabolism	2011	51
21562325	3630	Steck AK	Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.	Diabetes care	2011	63
21617108	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Diabetes care	2011	75
21617152	3630	Sacks DB	Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.	Clinical chemistry	2011	60
22124462	3630	Yu L	Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay.	Diabetes	2012	37
22245737	3630	Bulek AM	Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.	Nature immunology	2012	57
22313123	3630	Peyrot M	Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study.	Diabetic medicine 	2012	103
22350783	3630	Deng L	Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis.	Digestive diseases and sciences	2012	38
22352879	3630	King AJ	The use of animal models in diabetes research.	British journal of pharmacology	2012	127
22486204	3630	George PS	Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis.	Diabetic medicine 	2012	66
22494609	3630	Bellin MD	Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.	American journal of transplantation 	2012	68
22521071	3630	Heller S	Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.	Lancet	2012	77
22777524	3630	Yeh HC	Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.	Annals of internal medicine	2012	57
23086558	3630	Herold KC	Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.	Diabetologia	2013	31
23359039	3630	Haidar A	Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.	CMAJ 	2013	39
23393185	3630	Mathieu C	Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.	The Journal of clinical endocrinology and metabolism	2013	44
23413806	3630	Jones AG	The clinical utility of C-peptide measurement in the care of patients with diabetes.	Diabetic medicine 	2013	58
23638642	3630	Gu Z	Injectable nano-network for glucose-mediated insulin delivery.	ACS nano	2013	37
23796113	3630	Östenson CG	Self-reported non-severe hypoglycaemic events in Europe.	Diabetic medicine 	2014	34
23850509	3630	Chen Z	Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.	Progress in neurobiology	2013	67
24663222	3630	Laakso M	Insulin resistance and hyperglycaemia in cardiovascular disease development.	Nature reviews. Endocrinology	2014	44
25287289	3630	Frier BM	Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.	Nature reviews. Endocrinology	2014	40
25642774	3630	Herold KC	β cell death and dysfunction during type 1 diabetes development in at-risk individuals.	The Journal of clinical investigation	2015	38
26678809	3630	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	44
26740634	3630	Tauschmann M	Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.	Diabetes care	2016	20
28118453	3630	Beck RW	Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.	JAMA	2017	43
28118454	3630	Lind M	Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.	JAMA	2017	24
28134564	3630	Garg SK	Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.	Diabetes technology and therapeutics	2017	28
16123337	3767	Hattersley AT	Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.	Diabetes	2005	96
18823656	5972	Chaturvedi N	Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.	Lancet	2008	77
24334175	5972	Cherney DZ	Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.	Circulation	2014	145
25349246	5972	Ding Y	Autophagy in diabetic nephropathy.	The Journal of endocrinology	2015	30
21636801	6347	Lassenius MI	Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.	Diabetes care	2011	76
24475922	6524	Cherney DZ	The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.	Cardiovascular diabetology	2014	63
24595630	6524	Perkins BA	Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.	Diabetes care	2014	43
25271207	6524	Henry RR	Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.	Diabetes care	2015	36
25341005	6524	Vallon V	The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.	Annual review of medicine	2015	27
26078479	6524	Peters AL	Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition.	Diabetes care	2015	67
15996257	7124	Froud T	Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.	American journal of transplantation 	2005	87
22266664	7124	Gohda T	Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.	Journal of the American Society of Nephrology 	2012	86
15971062	7421	Mathieu C	Vitamin D and diabetes.	Diabetologia	2005	90
18801384	7421	Holick MF	The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.	Molecular aspects of medicine	2008	61
20736230	7421	Ramagopalan SV	A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.	Genome research	2010	231
15149314	7422	Schrijvers BF	The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.	Kidney international	2004	100
21546089	7422	Do DV	The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.	Ophthalmology	2011	61
22537617	7422	Do DV	One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.	Ophthalmology	2012	70
25012934	7422	Korobelnik JF	Intravitreal aflibercept for diabetic macular edema.	Ophthalmology	2014	76
25204977	7422	Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.	Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.	Diabetes	2015	34
9771706	7466	Inoue H	A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome).	Nature genetics	1998	125
18061654	9370	Fantuzzi G	Adiponectin and inflammation: consensus and controversy.	The Journal of allergy and clinical immunology	2008	84
10932183	9451	Delépine M	EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.	Nature genetics	2000	173
19073967	10019	Smyth DJ	Shared and distinct genetic variants in type 1 diabetes and celiac disease.	The New England journal of medicine	2008	218
21829393	10019	Plagnol V	Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.	PLoS genetics	2011	83
17632545	23274	Hakonarson H	A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.	Nature	2007	187
24949970	23274	Soleimanpour SA	The diabetes susceptibility gene Clec16a regulates mitophagy.	Cell	2014	34
15934099	26191	Hinks A	Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene.	Arthritis and rheumatism	2005	72
16697661	26191	Bottini N	Role of PTPN22 in type 1 diabetes and other autoimmune diseases.	Seminars in immunology	2006	67
11120765	50943	Chatila TA	JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.	The Journal of clinical investigation	2000	200
12161590	50943	Wildin RS	Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.	Journal of medical genetics	2002	145
18981158	50943	Schneider A	The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.	Journal of immunology	2008	95
19128359	50943	Willcox A	Analysis of islet inflammation in human type 1 diabetes.	Clinical and experimental immunology	2009	150
19875613	50943	Long SA	Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.	Diabetes	2010	81
21896932	50943	Ferraro A	Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.	Diabetes	2011	53
24704576	50943	Marek-Trzonkowska N	Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.	Clinical immunology	2014	49
26606968	50943	Bluestone JA	Type 1 diabetes immunotherapy using polyclonal regulatory T cells.	Science translational medicine	2015	115
23359064	51497	Yang CY	The implication of vitamin D and autoimmunity: a comprehensive review.	Clinical reviews in allergy and immunology	2013	33
19940299	54474	Pescovitz MD	Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.	The New England journal of medicine	2009	256
26581594	54474	Campbell-Thompson M	Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes.	Diabetes	2016	42
12815107	57818	Lieberman SM	Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2003	113
20357361	57818	Velthuis JH	Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers.	Diabetes	2010	59
16699517	64135	Smyth DJ	A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region.	Nature genetics	2006	201
18927125	64135	Liu S	IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells.	Human molecular genetics	2009	47
19264985	64135	Nejentsev S	Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes.	Science	2009	372
20351698	64135	Hober D	Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host.	Nature reviews. Endocrinology	2010	67
17942684	169026	Wenzlau JM	The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.	Proceedings of the National Academy of Sciences of the United States of America	2007	241
18591387	169026	Wenzlau JM	A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.	Diabetes	2008	57
20858685	169026	Stene LC	Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY).	Diabetes	2010	65
21067382	169026	Knip M	Dietary intervention in infancy and later signs of beta-cell autoimmunity.	The New England journal of medicine	2010	62
22289814	169026	Ziegler AG	Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes.	Diabetologia	2012	48
15123604	387082	Bohren KM	A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus.	The Journal of biological chemistry	2004	87
